Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Sterilants Market Outlook- 2023 to 2033

By 2033, the global sterilants market is expected to reach US$ 4244.1 million, surpassing US$ 2361.627 million in 2023. A CAGR of 6% indicates positive market growth over the forecast period.

Sterilization is one of the most important processes to be followed in industries and healthcare facilities. The rising incidence of infection transmission through surgical instruments or contaminated surface contact with the human skin surface or tissues has demanded effective and compatible sterilants or sporicidal agents in the sterilants market.

The growing demand for sterilized environments (in terms of sterilized surgical instruments and equipment) and surging demand for compatible sterilants have driven opportunities for manufacturers. Strategic acquisitions and collaborations by the manufacturers are leading to high growth of the sterilants market in the coming years. Also, the global pandemic has boosted the requirement for hygiene solutions, which amplifies the growth potential of the market.

The increasing demand for processed food, which uses sterilants as food preservatives to increase shelf life and protect them against microorganisms, is a major driver of the sterilant market. In addition, the growing healthcare industry contributes to the growth of the global sterilant market, since medical equipment needs to be sterilized with sterilants such as peracetic acid.

In the coming years, the global sterilant market is expected to grow due to the increasing use of sterilants in agriculture to protect crops. Furthermore, sterilants such as peracetic acid are environmentally friendly, making them preferred for sterilizing medical equipment; they also do not leave any toxic residue after application, making them an opportunistic market for the forecast period.

The application of sterilants to the body can, however, cause adverse health effects, such as irritation of the eyes, allergies, and respiratory irritation. The high concentration of some sterilants is corrosive in nature, resulting in the degradation of inanimate surfaces; as a result, the growth of the sterilants market is predicted to suffer during the forecast period.

Attributes Details
Sterilants Market Value (2023) US$ 2361.627 million
Sterilants Market Expected Value (2033) US$ 4244.1 million
Sterilants Market Projected CAGR (2023 to 2033) 6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Global Sterilants Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

Sterilization is an essential step to be carried out by laboratories and industries to avoid contamination and incidence of microbial transmission in aseptic areas. Sterilizing heat-sensitive instruments and surgical equipment that are highly susceptible to high temperatures can damage the instrument due to high temperatures or chemical reactions between the chemical sterilants and the instrument.

Thus, to avoid damage and the occurrence of chemical reactions, the demand for cold sterilants that are compatible and effective with low toxicity factors has increased. Consequently, the demand for sterilants is growing steadily owing to their strength and efficacy as compared to disinfectants.

According to FMI’s analysis, sterilants sales may grow from 2240.4 million in 2022 at a 19.7% CAGR between 2017 and 2022. The pandemic has strengthened the sales of sterilants and high-level disinfectants. Government initiatives to create awareness among people about hygienic environments are another factor expected to drive the sterilants market.

  • Short Term (2022 to 2025): The short-term growth prospects of the market are likely to grow as manufacturers may come up with campaigns that highlight the benefits of sterilants.
  • Medium Term (2025 to 2028): The market is likely to show a slight uptake as it could increase the adoption and usage of environmentally friendly and sustainable sterilants that offer improved efficacy and reduced toxicity.
  • Long Term (2028 to 2033): The long-term goal for the sterilants market would be innovative sterilization technologies that achieve high levels of efficacy while minimizing the use of harmful chemicals and reducing waste.
Historical CAGR 5.3%
Historical Market Value (2022) US$ 2240.4 million
orecast CAGR 6%

Comparative Analysis of Adjacent Sterilants Markets

Sterilants Market:

Differentiating Aspects Sterilants Market
CAGR (2023 to 2033) 6%
Market Valuation in 2023 US$ 2361.627 million
Projected Market Value in 2033 US$ 4244.1 million
Growth Factors Growing demand for processed foods that are preservative-free and use sterilant as preservatives.
Opportunities A surge in demand for compatible sterilants and sterilized environments has created opportunities for manufacturers.
Key Trends A growing trend in the global sterilants market is low-temperature sterilization over steam sterilization.

Allergy Immunotherapy Market:

Differentiating Aspects Allergy Immunotherapy Market
CAGR (2023 to 2033) 8.9%
Market Valuation in 2023 US$ 1.74 billion
Projected Market Value in 2033 US$ 4.07 billion
Growth Factors Patients and healthcare professionals are becoming more aware of the benefits
Opportunities Self-administered allergy immunotherapy products are in high demand
Key Trends Sublingual immunotherapy is becoming more popular than traditional allergy shots

Allergy Care Market:

Differentiating Aspects Allergy Care Market
CAGR (2023 to 2033) 6.1%
Market Valuation in 2023 US$ 23.34 billion
Projected Market Value in 2033 US$ 42.20 billion
Growth Factors Developing countries are expanding their healthcare infrastructure and increasing their healthcare expenditures
Opportunities Initiatives to reduce the burden of allergic diseases by the government
Key Trends Growing demand for allergy care solutions that target specific allergies
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comprehensive Analysis of the Factors Shaping the Sterilants Market

The rising incidence of healthcare-associated infections due to the cross-contamination of surgical instruments or equipment along with the growing preference for an aseptic environment is expected to propel the sterilants market in the coming years.

Rising demand for cold sterilants to avoid damage to heat-sensitive instruments is also likely to drive market growth. Manufacturers have increased their focus on research and development efforts to launch new and effective formulations to leverage market growth. Moreover, government initiatives to support hygiene solutions are expected to boost the sterilants market growth during the forecast period.

Due to the pandemic, the rising demand for hygienic environments to avoid unnecessary exposure to infectious diseases or viruses in hospitals and clinics has driven the global demand for sterilants around the world. Government decisions to combat viral exposure have raised the approval rates for new products in the market.

For instance, in September 2020, EcoClear Products, Inc. received Environmental Protection Agency (EPA) approval for SteriCide™, a multi-use disinfectant, for use against emerging viral pathogens, including SARS-CoV-2 (COVID-19). EcoClear Products, Inc. is a leading cleaning solution and pest control company in the United States. Moreover, in April 2020, Solvay SA received EPA approval for PROXITANE® AHC for use against SARS-CoV-2 – the virus strain.

Sterilants are Under Pressure from Several Factors

Regulatory complexity is the major factor expected to hamper the market growth. The utilization of high-level disinfectants or sterilants should be within the legal concentration range. For example, glutaraldehyde is normally used in the concentration range of 2 to 3%, but due to its high toxicity, the United States Environmental Protection Agency has limited its use.

Further, being a toxic chemical, the disposal of sterilants is another big challenge, as they are harmful to the environment. Numerous legal regulations implied by the Occupational Safety and Health Administration (OSHA) on waste disposal of disinfectants are forcing Forms to decrease the consumption of these chemicals. Due to the health and environmental hazards associated with chemical sterilants, numerous alternatives have been adopted by market players, which is expected to hamper the global sterilants market’s growth in the coming years.

Moreover, direct contact of high concentrations of sterilants with the skin is corrosive. According to the National Institute for Occupational Safety and Health, acute or chronic exposure to various sterilants may cause cancer, adverse reproductive effects, respiratory irritation, headaches, nausea, shortness of breath, mutagenic changes, neurotoxicity, sensitization, and many other adverse effects.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

The Sterilants Market is Characterized by a series of Key Trends

Increasing market consolidation activities including strategic acquisitions and collaborations between local players and the leading key players are a key trend impacting the sterilants market. The growing demand for low-temperature sterilization over steam sterilization is an emerging trend in the global sterilants market.

As all medical and scientific equipment is not able to resist the high temperature and humidity of the steam sterilization method, a suitable low-temperature sterilization method is required in the industrial sterilization field.

Several medical device companies are adopting low-temperature oxidative sterilization technology. This is based on two of these low-temperature oxidative methods, including peracetic acid gas/plasma technology and hydrogen peroxide plasma sterilization, developed by Advanced Sterilization Products (ASP).

The leading pharmaceutical players in the global market are adopting outsourcing models to expand their market footprint and thus generate a high rate of interest in the global sterilants market. Strategic long-term agreements and partnerships with local suppliers help manufacturers lower their operational costs. Furthermore, sterilants manufacturer companies can benefit from better pricing by outsourcing.

Overall run time and transportation and logistics costs are reduced to a great extent, which may benefit the key players in gaining a high revenue share in the market. For instance, In June 2018, Cantel Medical Corporation acquired Stericyle Inc.'s Controlled Environmental Solutions business, a leading provider of testing and certification, environmental monitoring, and decontamination services for cleanrooms and other controlled environments to ensure safety, regulatory compliance, and quality control.

Opportunities in the Sterilants Market that can be Exploited

The pharmaceutical & biotechnology industries have more emphasis on the maintenance of proper hygiene and providing an anti-bacterial environment in the manufacturing plant. Stringent regulations are followed by manufacturing plants focusing on the maintenance of hygiene and workplace safety, as even minor contamination during product manufacturing can lead to hazardous health issues.

In the United States, investments in research and development in the pharmaceutical sector have continuously increased in recent years and constitute over 40% of the global research and development investment in the pharmaceutical industry. Therefore, it is expected that the demand for sterilants will increase along with the growth of the pharmaceutical and biotechnology industries during the forecast period.

The growing healthcare sector also offers lucrative opportunities for manufacturers in the sterilants market. Governmental guidelines defined under the Affordable Care Act force hospital authorities to maintain cleanliness and hygiene services.

According to a Centers for Disease Control and Prevention (CDC) report, one out of 20 patients acquires an infection during a hospital visit in the United States. 75,000 people died due to such infections in 2014. Therefore, hospitals and consumers are increasingly adopting sterilants and disinfectants to reduce contamination and infection in hospitals.

Thus, infection control actions are expected to drive the market of sterilants during the forecast period. Furthermore, increased research and development efforts by manufacturers and researchers to develop novel and effective aseptic solutions and expansion of their product portfolio are expected to lead to lucrative opportunities in the competitive sterilants market.

Sterilants Market Category-wise Insights

Ethylene Oxide Gained Popularity in the Sterilants Market

Ethylene oxide (EO) sterilants are the most common industrial sterilants used for medical device sterilization. It is used in a ‘cold’ sterilization technique and offers high compatibility with most materials used in the manufacture of medical devices, such as plastics, polymers, metals, and glass.

Its lethality is driven by a chemical reaction (alkylation) with the DNA of bacteria, viruses, molds, yeasts, and even insects. Thus, owing to its advantage and compatibility ethylene oxide has the highest revenue share of US$ 605.31 million in 2023 and is expected to rise to annual revenue of US$ 995.42 million by 2033 with a 5.1% CAGR between 2023 and 2033.

What is the preferred form of Sterilants and who is the Leading End User?

The liquid sterilant form accounted for the highest share among the other forms owing to its compatibility with thermolabile products.

The hospital’s segment accounted for the highest share of the sterilants market with a CAGR of 4.5%. The overall demand for sterilants in hospitals is largely driven by the increasing prevalence of human-associated infections (HAIs), the growing number of surgical procedures, and the increasing number of hospitals worldwide.

The rising geriatric population is one of the key contributors to the sterilants market growth for hospitals. As the geriatric population is more susceptible to chronic diseases.

Region-Wise Insights

Countries Leading in Sterilants Market: Country-Wise Analysis

Region North America
Country United States
Historic CAGR 18.9%
Forecasted CAGR 5.2%
Absolute Dollar Growth US$ 30.6 million
Market Value (2033) US$ 1095.4 million
Region North America
Country Canada
Historic CAGR 16.9%
Forecasted CAGR 3.2%
Absolute Dollar Growth US$ 2.50 million
Market Value (2033) US$ 119.1 million
Region Europe
Country Germany
Historic CAGR 18.2%
Forecasted CAGR 1.8%
Absolute Dollar Growth US$ 6.4 million
Market Value (2033) US$ 187.8 million
Region Europe
Country United Kingdom
Historic CAGR 3.4 %
Forecasted CAGR 3.9 %
Absolute Dollar Growth US$ 0.2 million
Market Value (2033) US$ 7 million
Region Asia Pacific
Country China
Historic CAGR 19.0%
Forecasted CAGR 6.3%
Absolute Dollar Growth US$ 10.3 million
Market Value (2033) US$ 333.6 million

The Demand for Sterilants High in the United States

In the United States, the healthcare system is well known for its high expenses and well-developed infrastructure. The United States government and regulatory bodies are implementing various cost-effective plans to reduce their healthcare burden. Moreover, the heavy consumption of sterilants in the country, pushed by the high demand for sterility and hygiene maintenance due to the pandemic and to avoid infection exposure, the country has witnessed a huge growth rate over the past few months.

The country experienced the toughest hit of the infection, with a large number of cases diagnosed and the highest proportionate death rate recorded globally. As a result, Americans spent liberally on sterility measures, which resulted in growth in consumption of the same. Furthermore, the presence of leading players like 3M Company, Steris Plc., Cantel Medical Corporation, Thor Group, and many others in the region also helped drive the market in the region.

Rising Disposable Income in China to Create a Surge

Increasing disposable income could project a significant impact on economic development in emerging countries which results in the affordability of proper healthcare treatment. China’s per capita disposable income reached about US$ 4,961 in 2020, which doubled the level in 2010.

The potential for rising disposable income with high healthcare insurance is expected to contribute to increasing the affordability of healthcare services intended to prevent infectious diseases. The market in China is expected to witness significant growth at a CAGR of around 6.3%.

The Expansion of the Research Industry Drive the India Sterilants Market

The strong emergence of biopharmaceutical and pharmaceutical companies with growing research efforts is expected to offer opportunities in the sterilants market. However, India has the highest consumption of sterilants as compared to other South Asian countries. Sterilization demand is expected to increase, as most products in the pipeline are likely to reach the end stage and be commercialized by the end of the decade.

In developing countries, it is easier to recruit patients for clinical trials. Research and development costs in India are substantially less compared to those in developed countries, and it is possible to innovate and develop effective products at competitive rates. India accounted for more than 45% of the South Asia sterilants market.

Some of the key players in the Sterilants market are

  • 3M Company
  • Steris Plc.
  • Cantel Medical Corporation
  • Evonik Industries AG
  • Arkema S.A.
  • Thor Group
  • Metrex Research, LLC
  • Ecolab Inc.
  • Solvay SA
  • LANXESS
  • Contec, Inc.
  • OZU Corporation
  • Cetylite, Inc.
  • Veltek Associates, Inc.
  • Whiteley Corporation
  • Gul Biyoloji Laboratuvari

Recent Development

Many leading players are focusing on various market consolidation activities such as mergers, acquisitions, supply distribution partnerships, and launching new products, leading to high competitiveness in the market. Key manufacturers are keen to expand the market footprint of their key products and provide solutions to end users. For instance, many leading manufacturers nowadays provide customized solutions based on various end-user requirements.

  • In October 2021, Astell Scientific launched the latest AstellBio Sink line of Effluent Decontamination Systems (EDS) capable of automatically sterilizing polluted wastewater before releasing it into the sewer system. By deactivating biological agents up to and including level 3, the AstellBio Sink is capable of deterring the spread of harmful organisms.
  • Earlier this year, Sodexo announced its partnership with Ecolab Inc. to offer healthcare facilities and hospitals across the country the latest in infection prevention products and services. By utilizing Ecolab's Bioquell hydrogen peroxide vapor technology, Protecta Plus, Sodexo's unique program, offers an additional way to reduce the threat of infection.
  • In 2020, in response to the pandemic situation, Lanxess launched a high-level disinfectant named Rely+On Virkon. The product will be highly effective on hard surfaces and equipment, which will help to reduce the contamination of surfaces.

Thus, the ongoing innovative product offerings by market players can maintain supply and demand, assisting the overall market growth during the forecast period.

Scope of Report

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis US$ million for Value and MT for Volume
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia
Key Countries Covered USA, Canada, Brazil, Mexico, Chile, Peru, Germany, UNITED KINGDOM, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey
Key Segments Covered
  • Product
  • Form
  • End User
  • Region
Key Companies Profiled
  • 3M Company
  • Steris Plc.
  • Cantel Medical Corporation
  • Evonik Industries AG
  • Arkema S.A.
  • Thor Group
  • Metrex Research, LLC
  • Ecolab Inc.
  • Solvay SA
  • LANXESS
  • Contec, Inc.
  • OZU Corporation
  • Cetylite, Inc.
  • Veltek Associates, Inc.
  • Whiteley Corporation
  • Gul Biyoloji Laboratuvari
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Sterilants Market Segmentation by Category

By Product:

  • Ethylene Oxide (EtO)
  • Glutaraldehyde
  • Hydrogen Peroxide Gas Plasma (HPGP)
  • Vaporized Hydrogen Peroxide
  • Immersion and Vapor Phase Peracetic Acid
  • Others

By Form:

  • Liquid
  • Spray

By End-user:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Reference Laboratories
  • Rehabilitation Centers
  • Long Term Care Centers
  • Critical Care Centers
  • Pharmaceutical & Biotechnology Companies
  • Academics and Research Institutes
  • Homecare Settings

By Region:

  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia

Frequently Asked Questions

How is the Historical Performance of the Market?

During 2017 to 2022, the market recorded a CAGR of 5.3%.

What Drives the Growth Potential of the Sterilants Market?

Consumers seek preservative-free, natural processed foods raising the market growth.

Which is the Top Trend in the Market?

The increasing demand for heat-sensitive medical devices and supplies is the top trend.

Which Country is Dominating the Industry?

The United States is dominating the industry.

What is the Predicted Valuation of the Market by 2033?

The market is likely to surpass US$ 4244.1 million by 2033.

Table of Content

1. Executive Summary | Sterilants Market 

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. Ethylene Oxide

        5.3.2. Glutaraldehyde

        5.3.3. Hydrogen Peroxide Gas Plasma

        5.3.4. Vaporized Hydrogen Peroxide

        5.3.5. Immersion and Vapour Phase Peracetic Acid

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Form, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Form, 2023 to 2033

        6.3.1. Liquid

        6.3.2. Spray

    6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user 

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End-user , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-user , 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Clinics

        7.3.3. Ambulatory Surgical Centres

        7.3.4. Rehabilitation Centres

        7.3.5. Diagnostic Laboratories

        7.3.6. Pharmaceutical & Biotechnology Companies

        7.3.7. Academics and Research Institutes

    7.4. Y-o-Y Growth Trend Analysis By End-user , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End-user , 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Form

        9.2.4. By End-user 

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Form

        9.3.4. By End-user

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Form

        10.2.4. By End-user

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Form

        10.3.4. By End-user

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Product

        11.2.3. By Form

        11.2.4. By End-user

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Form

        11.3.4. By End-user

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Product

        12.2.3. By Form

        12.2.4. By End-user

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Form

        12.3.4. By End-user

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Product

        13.2.3. By Form

        13.2.4. By End-user

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Form

        13.3.4. By End-user

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Product

        14.2.3. By Form

        14.2.4. By End-user

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Form

        14.3.4. By End-user

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Form

        15.2.4. By End-user

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Form

        15.3.4. By End-user

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product

            16.1.2.2. By Form

            16.1.2.3. By End-user

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product

            16.2.2.2. By Form

            16.2.2.3. By End-user

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product

            16.3.2.2. By Form

            16.3.2.3. By End-user

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product

            16.4.2.2. By Form

            16.4.2.3. By End-user

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product

            16.5.2.2. By Form

            16.5.2.3. By End-user

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product

            16.6.2.2. By Form

            16.6.2.3. By End-user

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product

            16.7.2.2. By Form

            16.7.2.3. By End-user

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product

            16.8.2.2. By Form

            16.8.2.3. By End-user

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product

            16.9.2.2. By Form

            16.9.2.3. By End-user

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product

            16.10.2.2. By Form

            16.10.2.3. By End-user

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product

            16.11.2.2. By Form

            16.11.2.3. By End-user

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product

            16.12.2.2. By Form

            16.12.2.3. By End-user

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product

            16.13.2.2. By Form

            16.13.2.3. By End-user

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product

            16.14.2.2. By Form

            16.14.2.3. By End-user

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product

            16.15.2.2. By Form

            16.15.2.3. By End-user

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product

            16.16.2.2. By Form

            16.16.2.3. By End-user

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product

            16.17.2.2. By Form

            16.17.2.3. By End-user

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product

            16.18.2.2. By Form

            16.18.2.3. By End-user

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product

            16.19.2.2. By Form

            16.19.2.3. By End-user

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product

            16.20.2.2. By Form

            16.20.2.3. By End-user

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product

            16.21.2.2. By Form

            16.21.2.3. By End-user

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Form

        17.3.4. By End-user

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. 3M Company

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Steris Plc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Cantel Medical Corporation

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Evonik Industries AG

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Arkema S.A.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Thor Group

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Metrex Research, LLC

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Ecolab Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Solvay SA

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. LANXESS

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

        18.1.11. Contec, Inc.

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

        18.1.12. OZU Corporation

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

        18.1.13. Cetylite, Inc.

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

        18.1.14. Veltek Associates, Inc.

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

        18.1.15. Whiteley Corporation

            18.1.15.1. Overview

            18.1.15.2. Product Portfolio

            18.1.15.3. Profitability by Market Segments

            18.1.15.4. Sales Footprint

            18.1.15.5. Strategy Overview

                18.1.15.5.1. Marketing Strategy

        18.1.16. Gul Biyoloji Laboratuvari

            18.1.16.1. Overview

            18.1.16.2. Product Portfolio

            18.1.16.3. Profitability by Market Segments

            18.1.16.4. Sales Footprint

            18.1.16.5. Strategy Overview

                18.1.16.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Sterilization Equipment Market

Published : June 2024

Explore Healthcare Insights

View Reports